Natixis’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-2,703
| Closed | -$15.4K | – | 1047 |
|
2023
Q1 | $15.4K | Sell |
2,703
-168
| -6% | -$958 | ﹤0.01% | 865 |
|
2022
Q4 | $29K | Buy |
+2,871
| New | +$29K | ﹤0.01% | 900 |
|
2021
Q3 | – | Sell |
-2,891
| Closed | -$251K | – | 1225 |
|
2021
Q2 | $251K | Buy |
+2,891
| New | +$251K | ﹤0.01% | 798 |
|